DiaMedica Therapeutics Inc.
DMAC
$5.67
-$0.13-2.24%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -40.33% | -14.34% | 2.30% | -37.59% | -46.16% |
| Total Depreciation and Amortization | 25.00% | 42.86% | 14.29% | 33.33% | 14.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,052.63% | -15.88% | -24.36% | -64.21% | -95.15% |
| Change in Net Operating Assets | 546.18% | 161.23% | -2,808.62% | 81.47% | -218.06% |
| Cash from Operations | 6.82% | 10.16% | -30.73% | -37.82% | -103.18% |
| Capital Expenditure | 10.00% | 100.00% | -28.57% | 90.63% | 76.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -562.35% | 116.84% | 67.61% | 28.83% | -42.98% |
| Cash from Investing | -566.97% | 116.84% | 67.72% | 29.64% | -42.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -50.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -68.10% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,150.00% | -68.11% | 0.00% | 0.00% | -200.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -175.35% | 224.19% | 5.23% | 18.09% | -1,139.52% |
